Discovery Engine
When healers on different continents — who never met — independently arrived at the same molecular treatment for the same condition, that's one of the strongest signals of real efficacy. Here's what we found.
How to read these results
Tier 1: Independent Polygenesis
Same compound found independently in 3+ traditions with no historical contact — the strongest signal.
Tier 2: Functional Convergence
Different plants but same mechanism of action across 2+ traditions.
Tier 3: Diffusion-Enhanced
Treatment spread between traditions but independently validated.
Tier 4: Single-Tradition Depth
Strong evidence in one tradition but no cross-tradition validation yet.
15 traditions independently converged on this treatment
14 traditions independently converged on this treatment
15 traditions independently converged on this treatment
12 traditions independently converged on this treatment
9 traditions independently converged on this treatment
7 traditions independently converged on this treatment
15 traditions independently converged on this treatment
15 traditions independently converged on this treatment
15 traditions independently converged on this treatment
15 traditions independently converged on this treatment
8 traditions independently converged on this treatment
2 traditions independently converged on this treatment
This represents strong molecular convergence with high pharmacological significance. While no identical compounds are shared, the traditions independently target the same six molecular pathways using structurally distinct molecules - AKBA from Boswellia (Ayurveda), Curcumin from Turmeric (Ayurveda),...
15 traditions independently converged on this treatment
7 traditions independently converged on this treatment
7 traditions independently converged on this treatment
This represents exceptionally strong molecular convergence with high independent discovery probability. Asiaticoside from Centella asiatica shows the most compelling evidence - this single species was independently adopted across 7 geographically isolated traditions (Asia, Africa, Pacific) targeting...
This represents exceptionally strong molecular convergence with profound pharmacological significance. The data shows four shared bioactive compounds across 14 independent medical traditions, with particularly striking patterns: (1) Charantin from Momordica charantia appears in 8 geographically disp...
This represents exceptionally strong molecular convergence. The identical compound Phyllanthin from the same species (Phyllanthus niruri) appears across 5 geographically isolated traditions spanning 4 continents - a classic example of independent discovery. Similarly, Protodioscin from Tribulus terr...
This represents exceptionally strong molecular convergence with high likelihood of independent discovery. The convergence spans three distinct pharmacological paradigms: (1) Anti-inflammatory via 6-gingerol/6-shogaol from Zingiber officinale across geographically separated traditions (Siddha, Unani,...
The molecular convergence is moderate but limited in scope. Only cinnamaldehyde from Cinnamomum verum shows true compound-level convergence, appearing across Ancient Egyptian, Korean Hanbang, and Japanese Kampo traditions. However, this likely represents cultural diffusion rather than independent di...
The molecular convergence is moderate but limited. The analysis reveals only one truly shared compound (glycyrrhizin) appearing in just two closely related traditions (TCM and Kampo), both using the identical species Glycyrrhiza uralensis. This represents clear cultural diffusion rather than indepen...
This represents exceptionally strong molecular convergence across geographically isolated traditions. The shared compounds show clear independent discovery patterns: Artemisinin (China/Korea/Africa), Quinine (Mesoamerica/Amazon), Salicin (Egypt/Greece), and Azadirachtin (India/Persia/Africa) all der...
This represents exceptionally strong molecular convergence with high likelihood of independent discovery. The most compelling evidence is 6-gingerol/6-shogaol from Zingiber officinale appearing independently across 6 geographically isolated traditions (Siddha, Mesoamerican, Polynesian, Unani, Amazon...
This represents exceptionally strong molecular convergence across 15 independent medical traditions. The evidence is compelling: identical bioactive compounds (6-gingerol, curcumin, salicin, glycyrrhizin, AKBA) independently discovered from the same plant species across geographically isolated cultu...
This represents exceptionally strong molecular convergence across geographically isolated traditions. The most compelling evidence is quercetin from Psidium guajava independently discovered across Mesoamerican, Amazonian, African, and Polynesian medicines - traditions with no historical contact yet ...
This represents exceptionally strong molecular convergence with high likelihood of independent discovery. The convergence operates on multiple levels: (1) Identical compounds from the same species (Curcumin from Curcuma longa in Siddha/Ayurveda, Acemannan from Aloe vera in Egyptian/African tradition...
This represents strong molecular convergence with significant pharmacological implications. Three distinct compound clusters emerged from geographically separated traditions: Shatavarin IV (South/Central Asian systems), Agnuside (Mediterranean/Mesoamerican), and Ligustilide (East Asian). The converg...
The molecular convergence is moderate but limited in scope. While costunolide demonstrates sophisticated multi-target activity (NF-κB covalent inhibition, STAT3 suppression, AP-1 modulation), it's only found in Laurus nobilis across Ancient Greek and Unani traditions - systems with documented histor...
The molecular convergence here is relatively weak, limited to only two traditions (Ayurveda and Unani) using the identical compound Withaferin A from the same species (Withania somnifera). This represents cultural diffusion rather than independent discovery, as Unani medicine has extensive historica...